What is the prevalence of Lymphangiomatosis?

TL;DR: Lymphangiomatosis is a rare, complex disorder characterized by the diffuse proliferation of lymphatic vessels, with an estimated prevalence of less than 1 in 1,000,000 individuals. Because of its rarity and clinical complexity, true prevalence remains difficult to determine, as many cases likely remain undiagnosed or misclassified as other lymphatic malformations.

Is Lymphangiomatosis considered a rare disease?

Yes, Lymphangiomatosis is considered an ultra-rare disease. Epidemiological data is extremely limited, making it difficult to establish exact incidence rates. Most clinical literature classifies it as a systemic form of lymphatic malformation. While the exact number of people living with Lymphangiomatosis is unknown, the rarity of the condition often leads to significant diagnostic delays, which contributes to the scarcity of reliable global prevalence statistics.

Who is most affected by Lymphangiomatosis?

Lymphangiomatosis can manifest at any age, though it is most frequently diagnosed in children and young adults. Clinical observations suggest that the condition does not show a strong predilection for any specific ethnic or geographic group. Regarding gender, some studies indicate a slight female predominance in certain types of lymphatic disorders, but for Lymphangiomatosis specifically, current data is insufficient to definitively state a gender-based prevalence bias.

Why is prevalence data for Lymphangiomatosis difficult to measure?

Accurate reporting for Lymphangiomatosis is hindered by several systemic factors:

• Diagnostic Confusion: It is frequently misidentified as Generalized Lymphatic Anomaly (GLA) or Gorham-Stout disease in medical records.


• Underdiagnosis: Milder or asymptomatic cases may never be formally diagnosed or captured in medical registries.


• Lack of Centralized Registries: Because the disease is so rare, there are few large-scale longitudinal studies tracking incidence.

How does the DiseaseMaps community compare to clinical data?

While formal clinical databases struggle to capture the full scope of the disease, patient-led platforms provide essential qualitative data. Currently, 3 people with Lymphangiomatosis have joined the DiseaseMaps.org community. These real-world accounts are vital for understanding the patient journey, as they highlight the shared challenges of finding specialists and obtaining an accurate diagnosis for Lymphangiomatosis.

Next steps

• Consult with a specialist in vascular anomalies or a pediatric hematologist-oncologist.


• Seek a referral to a tertiary care center with a multidisciplinary vascular anomalies clinic.


• Connect with patient advocacy groups to share experiences and stay informed about research.


• Join the DiseaseMaps.org community to connect with others navigating a Lymphangiomatosis diagnosis.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• Orphanet: Rare diseases of the lymphatic system (ORPHA: 247656).


• NIH Genetic and Rare Diseases (GARD) Information Center: Lymphangiomatosis overview.


• OMIM (Online Mendelian Inheritance in Man): Clinical summaries on lymphatic malformations.


• International Society for the Study of Vascular Anomalies (ISSVA) classification guidelines.